Immunome IMNM Accrued payables for stock repurchases, including applicable excise tax
Accrued payables for stock repurchases, including applicable excise tax at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAssumed1.
The official record: Immunome’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's accrued payables for stock repurchases, including applicable excise tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's accrued payables for stock repurchases, including applicable excise tax?
- Immunome (IMNM) reported accrued payables for stock repurchases, including applicable excise tax of $0 in Q4 2025.
- What does accrued payables for stock repurchases, including applicable excise tax mean?
- This metric captures the total value of obligations recognized for stock repurchases that have been committed to but not yet settled in cash, including any associated excise taxes. It serves as a measure of pending financial commitments related to capital return programs. Tracking this helps investors understand the timing and magnitude of future cash outflows associated with share buyback activities.